Oxford Immunotec to Present at the Cowen and Company 35th Annual Health Care Conference
(Thomson Reuters ONE) -
OXFORD, United Kingdom and MARLBOROUGH, Mass., Feb. 20, 2015 (GLOBE NEWSWIRE) --
Oxford Immunotec Global PLC (Nasdaq:OXFD), a global, commercial-stage
diagnostics company focused on developing and commercializing proprietary tests
for the management of immune-regulated conditions, today announced that Peter
Wrighton-Smith Ph.D., Chief Executive Officer, and Rick Altieri, Chief Financial
Officer, will present at the Cowen and Company 35(th) Annual Health Care
Conference at the Boston Marriott Copley Place Hotel in Boston, Massachusetts on
Wednesday, March 4, 2015 at 10:40 am ET.
A live webcast of the presentation will be available online from the investor
relations page of the Company's corporate website at www.oxfordimmunotec.com. A
webcast replay will be available approximately 24 hours after the live
presentation and will be archived on the website for approximately 60 days.
About Oxford Immunotec
Oxford Immunotec Global PLC is a global, commercial-stage diagnostics company
focused on developing and commercializing proprietary tests for the management
of immune-regulated conditions. The Company's initial product is the T-
SPOT(®).TB test, which is used to test for latent tuberculosis infection. The T-
SPOT.TB test has been approved for sale in over 50 countries, including the
United States, where it has received pre-market approval from the Food and Drug
Administration, Europe, where it has obtained a CE mark, as well as Japan and
China. The Company has an additional six products in various stages of
development that leverage the Company's proprietary technology for measuring
cellular (T cell) and innate immune responses. The two most advanced products
are focused on the transplantation market. The Company is headquartered near
Oxford, UK and in Marlborough, MA. Additional information can be found at
www.oxfordimmunotec.com.
T-SPOT and the Oxford Immunotec logo are trademarks of Oxford Immunotec Ltd.
CONTACTS:
For Media Inquiries:
Caroline Crawley
Oxford Immunotec
Tel: +44 1235 442796
ccrawley(at)oxfordimmunotec.com
For Investor Inquiries:
Rick Altieri
Chief Financial Officer
Oxford Immunotec
Tel: +1 (508) 573-9953
raltieri(at)oxfordimmunotec.com
Mark Klausner
Westwicke Partners
Tel: +1 (443) 213-0500
oxfordimmunotec(at)westwicke.com
This announcement is distributed by GlobeNewswire on behalf of
GlobeNewswire clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: Oxford Immunotec via GlobeNewswire
[HUG#1896262]
Unternehmensinformation / Kurzprofil:
Datum: 20.02.2015 - 17:38 Uhr
Sprache: Deutsch
News-ID 373175
Anzahl Zeichen: 3138
contact information:
Town:
Oxfordshire
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 172 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Oxford Immunotec to Present at the Cowen and Company 35th Annual Health Care Conference"
steht unter der journalistisch-redaktionellen Verantwortung von
Oxford Immunotec (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
